Psychiatr. praxi 2019; 20(3): 149-154

Život není jen sen

Na 18. ročníku česko‑ slovenského psychiatrického sjezdu, který proběhl 25.–27. září v brněnském hotelu International, proběhlo satelitní sympozium společnosti Angelini s názvem Život není jen sen. Sympozium se skládalo ze dvou přednášek věnovaných léčbě deprese, kde ústředním tématem bylo antidepresivum trazodon, jako účinná látka ovlivňující spánek i depresi. Přinášíme souhrn přednášek, které během sympozia zazněly. Svou převážně obecně zaměřenou přednáškou Letem receptorovým světem doc. MUDr. Martin Anders, Ph.D., seznámil posluchače na příkladu trazodonu s pohledem na etiopatogenezi deprese a vývoj poznání toho onemocnění. Věnoval se spotřebě antidepresiv v ČR a zemích OECD a nahlédl také do budoucnosti léčby deprese.

Published: October 11, 2019  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Život není jen sen. Psychiatr. praxi. 2019;20(3):149-154.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Anders M, Graf na základě dat ze SÚKL, AISLP, 2018.
    2. Delgado a kol. Biol Psychiatry. 1999; 46: 212-220.; Delgado and Moreno. J Clin Psychiatry. 2000; 61 (Suppl 1): 5-12. Go to original source...
    3. Saltiel P, Silvershein D. Neuropsychiatr Dis Treat. 2015; 11: 875-888.
    4. Stah SM., CNS Spectr. Vol 14 No 10, 2009 modified.
    5. Hayasaka Y a kol. Dose equivalents of antidepressants: Evidence-based recommendations from randomised controlled trials. Journal of Affective Disorders. 2018; 180: 179-184. Go to original source...
    6. Read J, Cartwright C, Gibson K. Adverse emotional and interpersonal effects reported by 1829 New Zealanders while taking antidepressants. Psychiatry Res. 2014 Apr 30; 216(1): 67-73. Go to original source... Go to PubMed...
    7. Trazodone Contramid(R) OAD Bioavailability Study 2010.
    8. Salvatori a kol. 2019 A Randomized, Double-Blind Study Comparing the Efficacy and Safety of Trazodone OAD and Venlafaxine XR for the Treatment of Patients With Major Depressive Disorder.
    9. Henssler J, Bschor T, Baethge C. Combining Antidepressants in Acute Treatment of Depression: A Meta-Analysis of 38 Studies Including 4511 Patients. Can J Psychiatry. 2016; 61(1): 29-43. Go to original source... Go to PubMed...
    10. Saletu-Zyhlars G a kol. Confirmation of the neurophysiologically predicted therapeutic effects of trazodone on its target symptoms depression, anxiety and insomnia by postmarketing clinical studies with a controlled-release formulation in depressed outpatients. Neuropsychobiology. 2003; 48(4): 194-208. Go to original source... Go to PubMed...
    11. Sheehan DV a kol. Extended-release Trazodone in Major Depressive Disorder: A Randomized, double-blind, Placebo-controlled Study,Psychiatry (Edgmont); 2009 May; 6(5): 20-33. Go to PubMed...
    12. Roth AJ a kol. Cognitive, Psychomotor, and Polysomnographic Effects of Trazodone in Primary Insomniacs. J Sleep Res. 2011 Dec; 20(4): 552-558. Go to original source... Go to PubMed...
    13. Češková E. a kol., Once-a-Day Trazodone in the Treatment of Depression in Routine Clinical Practice. Pharmacology. 2018; 102(3-4). Go to original source...
    14. La AL, Walsh CM, Neylan TC, et al. Long-Term Trazodone Use and Cognition: A Potential Therapeutic Role for Slow-Wave Sleep Enhancers. J Alzheimers Dis. 2019; 67(3): 911-921. Go to original source... Go to PubMed...

    Return to the content


    Psychiatry for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.